KOD
Price:
$9.25
Market Cap:
$486.77M
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry ...[Read more]
Industry
Biotechnology
IPO Date
2018-10-04
Stock Exchange
NASDAQ
Ticker
KOD
According to Kodiak Sciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 362.34M. This represents a change of 571.84% compared to the average of 53.93M of the last 4 quarters.
The mean historical Enterprise Value of Kodiak Sciences Inc. over the last ten years is 1.61B. The current 362.34M Enterprise Value has changed 2.15% with respect to the historical average. Over the past ten years (40 quarters), KOD's Enterprise Value was at its highest in in the December 2020 quarter at 6.19B. The Enterprise Value was at its lowest in in the March 2022 quarter at -187554073.04.
Average
1.61B
Median
274.95M
Minimum
-44536440.00
Maximum
5.85B
Discovering the peaks and valleys of Kodiak Sciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 13.80%
Maximum Annual Enterprise Value = 5.85B
Minimum Annual Increase = -116.41%
Minimum Annual Enterprise Value = -44536440.00
Year | Enterprise Value | Change |
---|---|---|
2023 | -44536440.00 | -116.41% |
2022 | 271.41M | -92.74% |
2021 | 3.74B | -36.12% |
2020 | 5.85B | 132.84% |
2019 | 2.51B | 13.80% |
2018 | 18.08M | -93.51% |
2017 | 278.50M | 6.96% |
The current Enterprise Value of Kodiak Sciences Inc. (KOD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.32B
5-year avg
2.47B
10-year avg
1.61B
Kodiak Sciences Inc.’s Enterprise Value is greater than Reviva Pharmaceuticals Holdings, Inc. (70.91M), greater than Eyenovia, Inc. (15.24M), greater than Cognition Therapeutics, Inc. (4.08M), greater than TransCode Therapeutics, Inc. (769.13K), greater than Assembly Biosciences, Inc. (67.83M), greater than Instil Bio, Inc. (220.42M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Spero Therapeutics, Inc. (-21358605.00), greater than CytomX Therapeutics, Inc. (55.32M), greater than Checkpoint Therapeutics, Inc. (165.69M), greater than Mustang Bio, Inc. (5.46M), greater than Reviva Pharmaceuticals Holdings, Inc. (70.91M), greater than Fortress Biotech, Inc. (60.71M), less than Intercept Pharmaceuticals, Inc. (915.81M), less than Madrigal Pharmaceuticals, Inc. (6.67B), less than Sarepta Therapeutics, Inc. (12.73B), less than Mirati Therapeutics, Inc. (3.91B), greater than Biomea Fusion, Inc. (67.66M), less than Stoke Therapeutics, Inc. (467.23M), less than Akero Therapeutics, Inc. (1.70B), greater than Homology Medicines, Inc. (-103303255.00), less than Gossamer Bio, Inc. (369.59M),
Company | Enterprise Value | Market cap |
---|---|---|
70.91M | $63.10M | |
15.24M | $9.42M | |
4.08M | $25.51M | |
769.13K | $2.49M | |
67.83M | $94.84M | |
220.42M | $141.74M | |
-6333315.00 | $8.20M | |
-21358605.00 | $50.31M | |
55.32M | $85.30M | |
165.69M | $170.39M | |
5.46M | $8.00M | |
70.91M | $76.39M | |
60.71M | $47.09M | |
915.81M | $794.69M | |
6.67B | $6.78B | |
12.73B | $11.53B | |
3.91B | $4.12B | |
67.66M | $146.04M | |
467.23M | $614.95M | |
1.70B | $1.98B | |
-103303255.00 | $3.02M | |
369.59M | $194.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kodiak Sciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kodiak Sciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Kodiak Sciences Inc.'s Enterprise Value?
What is the highest Enterprise Value for Kodiak Sciences Inc. (KOD)?
What is the 3-year average Enterprise Value for Kodiak Sciences Inc. (KOD)?
What is the 5-year average Enterprise Value for Kodiak Sciences Inc. (KOD)?
How does the current Enterprise Value for Kodiak Sciences Inc. (KOD) compare to its historical average?